We are live on ! Find out more
Aviva

Aviva Portfolio holdings

AUM $59.6B
1-Year Est. Return 28.44%
This Fund
S&P 500
This Quarter Est. Return
+5.72%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$20.5B
AUM Growth
+$1.25B
Cap. Flow
+$361M
Cap. Flow %
1.76%
Top 10 Hldgs %
22.52%
Holding
1,000
New
89
Increased
345
Reduced
485
Closed
62

Top Buys

Rank Stock Value
1
FERG icon
Ferguson
FERG
+$309M
2
STLA icon
Stellantis
STLA
+$198M
3
MA icon
Mastercard
MA
+$54.7M
4
TFC icon
Truist Financial
TFC
+$47.4M
5
DIS icon
Walt Disney
DIS
+$41.8M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$55.7M
2
SWKS icon
Skyworks Solutions
SWKS
+$47.7M
3
RTX icon
RTX Corp
RTX
+$38.8M
4
ADBE icon
Adobe
ADBE
+$35.9M
5
ICE icon
Intercontinental Exchange
ICE
+$32.7M

Sector Composition

Rank Sector Weight
1 Technology 20.63%
2 Financials 14.68%
3 Consumer Discretionary 13.35%
4 Healthcare 12.77%
5 Communication Services 10.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MU icon
76
Micron Technology
MU
$880B
$61M 0.3%
691,091
-57,471
-8% -$4.88M
ES icon
77
Eversource Energy
ES
$28.1B
$60.7M 0.3%
701,169
-4,162
-0.6% -$353K
IQV icon
78
IQVIA
IQV
$40.3B
$60.5M 0.3%
313,037
+16,983
+6% +$3.19M
CVS icon
79
CVS Health
CVS
$137B
$59.6M 0.29%
792,596
-75,484
-9% -$5.5M
MDLZ icon
80
Mondelez International
MDLZ
$83.9B
$59.2M 0.29%
1,011,341
-98,179
-9% -$5.54M
TXN icon
81
Texas Instruments
TXN
$250B
$59.1M 0.29%
312,655
-28,253
-8% -$4.91M
EW icon
82
Edwards Lifesciences
EW
$49B
$59M 0.29%
705,113
+343
+0% +$29K
BMY icon
83
Bristol-Myers Squibb
BMY
$130B
$56.9M 0.28%
900,559
-386,682
-30% -$24.1M
BAH icon
84
Booz Allen Hamilton
BAH
$8.57B
$56.5M 0.28%
701,531
+79,548
+13% +$6.68M
LLY icon
85
Eli Lilly
LLY
$1.09T
$55.6M 0.27%
297,849
+14,640
+5% +$2.86M
IWV icon
86
iShares Russell 3000 ETF
IWV
$19.4B
$54.3M 0.27%
228,716
+17,466
+8% +$4.06M
ALLE icon
87
Allegion
ALLE
$13.4B
$52.5M 0.26%
417,964
-186,543
-31% -$21.5M
AMGN icon
88
Amgen
AMGN
$210B
$52M 0.25%
209,182
-1,498
-0.7% -$357K
AVTR icon
89
Avantor
AVTR
$9.62B
$49.6M 0.24%
1,713,144
+220,433
+15% +$6.36M
PM icon
90
Philip Morris
PM
$313B
$49.5M 0.24%
557,578
+31,042
+6% +$2.64M
PTC icon
91
PTC
PTC
$15B
$48.7M 0.24%
353,863
+304,163
+612% +$40.5M
COP icon
92
ConocoPhillips
COP
$144B
$48.7M 0.24%
919,258
+112,920
+14% +$5.57M
TSM icon
93
TSMC
TSM
$1.97T
$47.4M 0.23%
400,793
-9,609
-2% -$1.19M
DHR icon
94
Danaher
DHR
$140B
$47M 0.23%
235,452
+1,174
+0.5% +$238K
LOW icon
95
Lowe's Companies
LOW
$122B
$47M 0.23%
247,020
-8,856
-3% -$1.52M
UBS icon
96
UBS Group
UBS
$171B
$47M 0.23%
3,026,012
-257,322
-8% -$3.96M
WYNN icon
97
Wynn Resorts
WYNN
$10.2B
$45.4M 0.22%
362,305
+85,745
+31% +$10.3M
AJG icon
98
Arthur J. Gallagher & Co
AJG
$68.9B
$45.1M 0.22%
361,602
-145,323
-29% -$17.5M
ZTS icon
99
Zoetis
ZTS
$32.8B
$44.9M 0.22%
285,367
+9,521
+3% +$1.51M
RY icon
100
Royal Bank of Canada
RY
$289B
$43.7M 0.21%
474,842
+2,478
+0.5% +$216K

Similar funds

Aviva's Q1 2021 Portfolio in Review

As of Q1 2021, Aviva held 1,000 positions worth $20.5B, up 6.5% from $19.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Aviva's Q1 2021 filing shows 89 new, 345 increased, 485 reduced and 62 closed positions. Its largest new stake was Ferguson: 2,534,285 shares worth $302M. The largest sale was Apple, an estimated $55.7M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Aviva's largest Q1 2021 buy was Ferguson: 2,534,285 shares worth $302M.
  • Aviva added most to Stellantis in Q1 2021, an estimated $198M increase.
  • Aviva's biggest Q1 2021 reduction was Apple, cutting an estimated $55.7M.
  • Aviva fully exited Tiffany & Co. in Q1 2021, selling an estimated $7.08M.
  • Aviva's ten largest holdings make up 23% of its $20.5B portfolio in Q1 2021.
  • Aviva opened 89 new positions and closed 62 in Q1 2021.
  • Aviva's portfolio value rose 6.5% quarter-over-quarter to $20.5B.

Based on Aviva's 13F filing for Q1 2021, filed 13 May 2021.